80 related articles for article (PubMed ID: 38689341)
1. Mechanism of PTPN18 for regulating the migration and invasion of endometrial cancer cells via the MYC/PI3K/AKT pathway.
Suo S; Chen S; Zhou L; Xu R; Li J; Li W
Histol Histopathol; 2024 May; ():18767. PubMed ID: 38855855
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid.
Guo X; Wan P; Shen W; Sun M; Peng Z; Liao Y; Huang Y; Liu R
J Transl Med; 2024 Apr; 22(1):401. PubMed ID: 38689341
[TBL] [Abstract][Full Text] [Related]
3. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
4. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
[TBL] [Abstract][Full Text] [Related]
5. Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt/β-catenin signaling pathway.
Wang T; Wang J; Ren W; Liu ZL; Cheng YF; Zhang XM
Thorac Cancer; 2020 Aug; 11(8):2316-2324. PubMed ID: 32657048
[TBL] [Abstract][Full Text] [Related]
6. Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression.
Wang P; Liu X; Han G; Dai S; Ni Q; Xiao S; Huang J
Cell Cycle; 2019 Sep; 18(18):2359-2376. PubMed ID: 31387451
[No Abstract] [Full Text] [Related]
7. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
8. Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry.
Parra-Rojas S; Velázquez-Cayón RT; Borges-Gil A; Mejías-Torrus JL; Cassol-Spanemberg J
Curr Oncol Rep; 2024 Apr; 26(4):391-399. PubMed ID: 38502418
[TBL] [Abstract][Full Text] [Related]
9. Genetic and molecular characterization of metabolic pathway-based clusters in esophageal squamous cell carcinoma.
Wang Z; Zhang Y; Yang X; Zhang T; Li Z; Zhong Y; Fang Y; Chong W; Chen H; Lu M
Sci Rep; 2024 Mar; 14(1):6200. PubMed ID: 38486026
[TBL] [Abstract][Full Text] [Related]
10. Metabolic remodeling in cancer and senescence and its therapeutic implications.
Kim Y; Jang Y; Kim MS; Kang C
Trends Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38453603
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15.
Zhu H; Li M; Bi D; Yang H; Gao Y; Song F; Zheng J; Xie R; Zhang Y; Liu H; Yan X; Kong C; Zhu Y; Xu Q; Wei Q; Qin H
Nat Commun; 2024 Feb; 15(1):1688. PubMed ID: 38402201
[TBL] [Abstract][Full Text] [Related]
12. Banxia Xiexin Decoction delays colitis-to-cancer transition by inhibiting E-cadherin/β-catenin pathway via Fusobacterium nucleatum FadA.
Jiang Y; Huang Y; Hu Y; Yang Y; You F; Hu Q; Li X; Zhao Z
J Ethnopharmacol; 2024 Jun; 328():117932. PubMed ID: 38382652
[TBL] [Abstract][Full Text] [Related]
13. Cancer statistics, 2024.
Siegel RL; Giaquinto AN; Jemal A
CA Cancer J Clin; 2024; 74(1):12-49. PubMed ID: 38230766
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]